Showing 51-60 of 66 results for "".
Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators, Part II
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators-part-ii/21593/Experts from different arenas in cosmetic dermatology discuss current and future developments.2023: The Year Ahead for the M&A and Capital Markets
https://practicaldermatology.com/topics/practice-management/2023-the-year-ahead-for-the-ma-and-capital-markets/23883/How would a recession impact your dermatology practice?Creating Loyal Patients
https://practicaldermatology.com/topics/practice-management/creating-loyal-patients/21360/A look at current research and best practices.Taking the Time: The Importance of Effective Communication with Patients
https://practicaldermatology.com/topics/general-topics/taking-the-time-the-importance-of-effective-communication-with-patients/21613/The hallmark of good communication with patients is managing expectations.The Contract: A Tool for Mapping the Future
https://practicaldermatology.com/topics/general-topics/the-contract-a-tool-for-mapping-the-future/22023/Many physician extenders focus on compensation and benefits without recognizing the importance of the contract in anticipating the “What ifs” in practice.What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?- Dr. Jacob Chacko Joins Bonti's Board of Directorshttps://practicaldermatology.com/news/dr-jacob-chacko-joins-bontis-board-of-directors/2457893/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Communications
- About 415 Million People May Have Rosacea Worldwidehttps://practicaldermatology.com/news/about-415-million-people-may-have-rosacea-worldwide/2457701/As many as 415 million people worldwide may have rosacea, according to new research in the British Journal of Dermatology. Dr. Jacob Thyssen and colleagues at the University of Copenhagen, Denmark, conducted
- LEO Pharma Adds to Global Leadership Teamhttps://practicaldermatology.com/news/leo-pharma-adds-to-global-leadership-team/2461607/Dr. Jacob Pontoppidan Thyssen is the new Executive Vice President and Chief Scientific Officer for LEO Pharma’s Research and Early Development arm. The company announced that a significant shift in R&D to a research model in early 2023. The change aims to drive the early-stage